Loading
JH
JD Health International Inc. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Liu Qiangdong Richard, was filed 15 May 2026.
Insider Decl.
114
Thresholds
n/a
Buy Volume
n/a
19 ops. · all time
Sell Volume
€124M
34 ops. · all time
Who traded when
BuySaleJIN Enlin1 buy6 sales
Lau George3 sales
Zhang Jiyu2 sales
CAO Dong1 buy
Chen Xingyao1 sale
Liu Qiangdong Richard1 buy
+1 other insider
Since the insiders bought
- -8.3%Entry HK$43.08 · Close at T+90 HK$39.50
- -26.0%Entry HK$51.30 · Close 22 Oct 2026 HK$37.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate JD Health International Inc. Strong Buy (bullish), based on 16 analysts. Average price target: HK$68.70.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,583 of 26,250 companies
58.2
score / 100
Value53
Quality64
FCF yld8.1%
Earn yld4.3%
EV/EBITDA19.7x
ROE10%
Gross mgn25%
Net mgn7.3%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$38.80
Analyst consensus
16 analystsStrong buy
HK$50.06Target HK$68.70(+77%)HK$96.25
Income statement
RevenueHK$73.4B
Gross profitHK$18.2B25% margin
EBITDAHK$6.3B9% margin
Net incomeHK$5.4B7.9% margin
Valuation
PER (trailing)17.9x
PER (forward)15.4x
P/Book1.7x
Beta1.19
Balance sheet & cash
Market capHK$123.8B
Total debtHK$636M
Free Cash FlowHK$10B
Debt / Equity1%
Profitability & ownership
ROE10.4%
ROA3.7%
% insiders68.2%
% institutions16.7%
Last declaration on 18 August 2026
Declarations114 total
12,963 sharesShareXHKGHKEX:DA20260817E00345
64,215,503 sharesShareXHKGHKEX:DA20260515E00291
Canonical exit: 13 Aug 2026 (T+90)
200,000 sharesShareXHKGHKEX:DA20260408E00521
Canonical exit: 30 Jun 2026 (T+90)
1,000 shares@ HK$46.820.0000% mcap32.4% of flowShareXHKGHKEX:DA20260408E00537
19,698 sharesShareXHKGHKEX:DA20260408E00518
2,000 shares@ HK$48.820.0001% mcap67.6% of flowShareXHKGHKEX:DA20260408E00538
8,009 sharesShareXHKGHKEX:DA20260408E00543
2,842 shares@ HK$47.49350.0001% mcap100.0% of flowShareXHKGHKEX:DA20260402E00477
9,224 sharesShareXHKGHKEX:DA20260402E00476
13,133 sharesShareXHKGHKEX:DA20260106E00487
7,165 sharesShareXHKGHKEX:DA20251128E00320
7,165 sharesShareXHKGHKEX:DA20251128E00316
8,840,419 sharesShareXHKGHKEX:DA20251017E00217
54,515 sharesShareXHKGHKEX:DA20251015E00431
3,000 shares@ HK$61.0056.1% of flowShareXHKGHKEX:DA20251015E00440
12,800 shares@ HK$67.6084.9% of flowShareXHKGHKEX:DA20250922E00411
158,800 shares@ HK$64.804823.3% of flowShareXHKGHKEX:DA20250825E00339
271,200 shares@ HK$63.37438.8% of flowShareXHKGHKEX:DA20250825E00338
12,963 sharesShareXHKGHKEX:DA20250818E00282
20,000 sharesShareXHKGHKEX:DA20250703E00475
9,180 shares@ HK$42.44980.9% of flowShareXHKGHKEX:DA20250703E00476
24,027 sharesShareXHKGHKEX:DA20250411E00530
Canonical exit: 9 Jul 2025 (T+90)
6,823 sharesShareXHKGHKEX:DA20250411E00531
42,126 shares@ HK$32.9483.3% of flowShareXHKGHKEX:DA20250409E00221
9,224 sharesShareXHKGHKEX:DA20250401E00355
25 of 114 declarations
About JD Health International Inc.
At JD Health International Inc., insiders hold 68.2% of the capital, an unusually high share for a healthcare company listed on the Hong Kong stock exchange and valued at HKD 123.8 billion. The record has 114 filings between December 22, 2020 and August 18, 2026, from 12 filers.
The largest amounts are sales by Liu Qiangdong Richard, Director: EUR 59,215,244 on March 30, 2023, EUR 29,644,107 on May 3, 2022 and EUR 23,627,263 on April 29, 2022. The 37 sales in the record come to EUR 123.5 million for the 36 that carry an amount, with a median of EUR 39,951.
Read moreShow less
The 19 purchases, or 34% of open-market trades, carry no amount in the filings, so they cannot be valued. From July 1 to July 16, 2021, 4 insiders did buy within the same fortnight. JIN Enlin, Director, is the top filer with 36 filings, of which 4 purchases and 13 sales. The yearly volume runs from 4 filings in 2020 to 25 in 2022. Over the last twelve months there are 12 filings, 2 purchases and 3 sales. Across all 114 filings with a measured delay, the median gap between trade and publication is 4 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
